Literature DB >> 32603652

Large SARS-CoV-2 Outbreak Caused by Asymptomatic Traveler, China.

Jingtao Liu, Jiaquan Huang, Dandan Xiang.   

Abstract

An asymptomatic person infected with severe acute respiratory syndrome coronavirus 2 returned to Heilongjiang Province, China, after international travel. The traveler's neighbor became infected and generated a cluster of >71 cases, including cases in 2 hospitals. Genome sequences of the virus were distinct from viral genomes previously circulating in China.

Entities:  

Keywords:  COVID-19; China; Heilongjiang; SARS; SARS-CoV-2; asymptomatic transmission; coronavirus; coronavirus disease; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses

Mesh:

Year:  2020        PMID: 32603652      PMCID: PMC7454089          DOI: 10.3201/eid2609.201798

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread rapidly around the world since the first cases were reported in late 2019 (,). Prior to April 9, 2020, Heilongjiang Province, China, had not reported a new COVID-19 diagnosis since March 11, 2020. On April 9, SARS-CoV-2 was diagnosed in 4 patients. By April 22, >71 persons had been infected. The likely origin of this cluster is an imported case from an asymptomatic traveler. We collected and analyzed epidemiologic data published on the website of the Health Commission of Heilongjiang Province for April 9–23, 2020 (). We defined confirmed COVID-19 cases as persons who tested positive for SARS-CoV-2 and had clinical symptoms. We defined asymptomatic carriers as persons without clinical symptoms who tested positive for SARS-CoV-2. We refer to case-patients by a letter for each family (A–Z, AA–ZZ), then by the assumed transmission generation (1–2), and finally in sequential order of exposure to SARS-CoV-2–positive persons in generations 1–3 (Figure) ().
Figure

Timeline of exposure and connections between cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among persons in Heilongjiang Province, China. A0 returned from the United States on March 19, tested negative for SARS-CoV-2, and self-quarantined in her apartment and remained asymptomatic. However, SARS-CoV-2 serum IgM was negative and IgG was positive in later retests, indicating that A0 was previously infected with SARS-CoV-2 and likely was an asymptomatic carrier. B1.1, A0’s downstairs neighbor, likely became infected by using the elevator in the building after A0 had used it.

Timeline of exposure and connections between cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among persons in Heilongjiang Province, China. A0 returned from the United States on March 19, tested negative for SARS-CoV-2, and self-quarantined in her apartment and remained asymptomatic. However, SARS-CoV-2 serum IgM was negative and IgG was positive in later retests, indicating that A0 was previously infected with SARS-CoV-2 and likely was an asymptomatic carrier. B1.1, A0’s downstairs neighbor, likely became infected by using the elevator in the building after A0 had used it. On March 19, 2020, case-patient A0 returned to Heilongjiang Province from the United States; she was asked to quarantine at home. She lived alone during her stay in Heilongjiang Province. She had negative SARS-CoV-2 nucleic acid and serum antibody tests on March 31 and April 3. Patient B1.1 was the downstairs neighbor of case-patient A0. They used the same elevator in the building but not at the same time and did not have close contact otherwise. On March 26, B1.1’s mother, B2.2, and her mother’s boyfriend, B2.3, visited and stayed in B1.1’s home all night. On March 29, B2.2 and B2.3 attended a party with patient C1.1 and his sons, C1.2 and C1.3. On April 2, C1.1 suffered a stroke and was admitted to hospital 1. His sons, C1.2 and C1.3, cared for him in ward area 1 of the hospital. Patient C1.1 shared the same clinical team and items, such as a microwave, with other patients in the ward. On April 6, patient C1.1 was transferred to hospital 2 because of fever; C1.2 and C1.3 accompanied him. On April 7, patient B2.3 first noted symptoms of COVID-19. He tested positive for SARS-CoV-2 on April 9, the first confirmed case in this cluster. His close contacts, B1.1, B2.1, B2.2, and C1.1, subsequently tested positive for SARS-CoV-2 on April 9 or 10. Patient C1.1 was quarantined in hospital 2 when he tested positive on April 9. The epidemiologic investigation showed that none of these 5 persons had a history of travel or residence in affected areas with sustained transmission of SARS-CoV-2 during the 14 days before diagnosis, suggesting that SARS-CoV-2 came from contact with other persons. During C1.1’s admission at hospital 1, a total of 28 other persons, D1.1–BB1.1, were infected with SARS-CoV-2 in ward area 1. Because all patients in the ward could ambulate, 4 persons, CC1.1, DD1.1, EE1.1, and FF1.1, were infected in other wards and in the computed tomography room of hospital 1. Among hospital 1 staff, 5 nurses and 1 doctor were infected. In hospital 2, another 20 persons, GG1.1–VV1.1, were infected in the ward where C1.1 stayed (Figure). On April 9, investigators also learned that A0, B1.1’s neighbor, had returned on March 19 from the United States, where COVID-19 cases had been detected. Investigators performed SARS-CoV-2 serum antibody tests on A0 on April 10 and 11. SARS-CoV-2 serum IgM was negative but IgG was positive, indicating that A0 was previously infected with SARS-CoV-2 (,). Therefore, we believe A0 was an asymptomatic carrier (,) and that B1.1 was infected by contact with surfaces in the elevator in the building where they both lived (). Other residents in A0’s building tested negative for SARS-CoV-2 nucleic acids and serum antibodies. On April 15, the Chinese Center for Disease Control and Prevention sequenced the entire genomes of 21 samples from the cluster. Viral genomes were identical in 18 cases and 3 other cases had a difference of 1–2 nucleotides, indicating that SARS-CoV-2 came from the same point of origin. The viral genome sequences from the cluster were distinct from the viral genomes previously circulating in China, indicating the virus originated abroad () and suggesting case A0 was the origin of infection for this cluster. All persons associated with this cluster, including those who lived in the same community and had close contact with SARS-CoV-2–positive patients or visited the 2 hospitals during April 2–15, were tested for SARS-CoV-2 nucleic acids and serum antibodies. As of April 22, 2020, A0 remained asymptomatic, and a total of 71 SARS-CoV-2–positive cases had been identified in the cluster. Our results illustrate how a single asymptomatic SARS-CoV-2 infection could result in widespread community transmission. This report also highlights the resources required for case investigation and challenges associated with containment of SARS-CoV-2. Continued measures to protect, screen, and isolate infected persons are essential to mitigating and containing the COVID-19 pandemic.
  8 in total

1.  Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient.

Authors:  Sean Wei Xiang Ong; Yian Kim Tan; Po Ying Chia; Tau Hong Lee; Oon Tek Ng; Michelle Su Yen Wong; Kalisvar Marimuthu
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

2.  Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.

Authors:  Kelvin Kai-Wang To; Owen Tak-Yin Tsang; Wai-Shing Leung; Anthony Raymond Tam; Tak-Chiu Wu; David Christopher Lung; Cyril Chik-Yan Yip; Jian-Piao Cai; Jacky Man-Chun Chan; Thomas Shiu-Hong Chik; Daphne Pui-Ling Lau; Chris Yau-Chung Choi; Lin-Lei Chen; Wan-Mui Chan; Kwok-Hung Chan; Jonathan Daniel Ip; Anthony Chin-Ki Ng; Rosana Wing-Shan Poon; Cui-Ting Luo; Vincent Chi-Chung Cheng; Jasper Fuk-Woo Chan; Ivan Fan-Ngai Hung; Zhiwei Chen; Honglin Chen; Kwok-Yung Yuen
Journal:  Lancet Infect Dis       Date:  2020-03-23       Impact factor: 25.071

3.  Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019.

Authors:  Yujiao Jin; Miaochan Wang; Zhongbao Zuo; Chaoming Fan; Fei Ye; Zhaobin Cai; Ying Wang; Huaizhong Cui; Kenu Pan; Aifang Xu
Journal:  Int J Infect Dis       Date:  2020-04-03       Impact factor: 3.623

4.  First Case of 2019 Novel Coronavirus in the United States.

Authors:  Michelle L Holshue; Chas DeBolt; Scott Lindquist; Kathy H Lofy; John Wiesman; Hollianne Bruce; Christopher Spitters; Keith Ericson; Sara Wilkerson; Ahmet Tural; George Diaz; Amanda Cohn; LeAnne Fox; Anita Patel; Susan I Gerber; Lindsay Kim; Suxiang Tong; Xiaoyan Lu; Steve Lindstrom; Mark A Pallansch; William C Weldon; Holly M Biggs; Timothy M Uyeki; Satish K Pillai
Journal:  N Engl J Med       Date:  2020-01-31       Impact factor: 91.245

5.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

6.  Potential False-Negative Nucleic Acid Testing Results for Severe Acute Respiratory Syndrome Coronavirus 2 from Thermal Inactivation of Samples with Low Viral Loads.

Authors:  Yang Pan; Luyao Long; Daitao Zhang; Tingting Yuan; Shujuan Cui; Peng Yang; Quanyi Wang; Simei Ren
Journal:  Clin Chem       Date:  2020-06-01       Impact factor: 8.327

7.  False-Negative Results of Real-Time Reverse-Transcriptase Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus 2: Role of Deep-Learning-Based CT Diagnosis and Insights from Two Cases.

Authors:  Dasheng Li; Dawei Wang; Jianping Dong; Nana Wang; He Huang; Haiwang Xu; Chen Xia
Journal:  Korean J Radiol       Date:  2020-03-05       Impact factor: 3.500

8.  Community Transmission of SARS-CoV-2 at Two Family Gatherings - Chicago, Illinois, February-March 2020.

Authors:  Isaac Ghinai; Susan Woods; Kathleen A Ritger; Tristan D McPherson; Stephanie R Black; Laura Sparrow; Marielle J Fricchione; Janna L Kerins; Massimo Pacilli; Peter S Ruestow; M Allison Arwady; Suzanne F Beavers; Daniel C Payne; Hannah L Kirking; Jennifer E Layden
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-04-17       Impact factor: 17.586

  8 in total
  14 in total

1.  Excess Risk of COVID-19 to University Populations Resulting from In-Person Sporting Events.

Authors:  Stephanie S Johnson; Katelin C Jackson; Matthew S Mietchen; Samir Sbai; Elissa J Schwartz; Eric T Lofgren
Journal:  Int J Environ Res Public Health       Date:  2021-08-04       Impact factor: 3.390

2.  Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests.

Authors:  Yutaro Yamaoka; Kei Miyakawa; Sundararaj Stanleyraj Jeremiah; Rikako Funabashi; Koji Okudela; Sayaka Kikuchi; Junichi Katada; Atsuhiko Wada; Toshiki Takei; Mayuko Nishi; Kohei Shimizu; Hiroki Ozawa; Shuzo Usuku; Chiharu Kawakami; Nobuko Tanaka; Takeshi Morita; Hiroyuki Hayashi; Hideaki Mitsui; Keita Suzuki; Daisuke Aizawa; Yukihiro Yoshimura; Tomoyuki Miyazaki; Etsuko Yamazaki; Tadaki Suzuki; Hirokazu Kimura; Hideaki Shimizu; Nobuhiko Okabe; Hideki Hasegawa; Akihide Ryo
Journal:  Cell Rep Med       Date:  2021-05-16

3.  Interpretation of laboratory tests for prevention of the SARS-CoV-2 transmission.

Authors:  Kenichi Masui
Journal:  J Anesth       Date:  2020-11-07       Impact factor: 2.078

4.  Phylogenomic tracing of asymptomatic transmission in a COVID-19 outbreak.

Authors:  Ju Zhang; Nan Ding; Yangzi Song; Rui Song; Yang Pan; Linghang Wang; Shuo Yan; Qi Wang; Shanfang Ma; Lirong Wei; Fengting Yu; Lianhe Lu; Fujie Zhang; Chen Chen; Hui Zeng
Journal:  Innovation (Camb)       Date:  2021-03-22

5.  Respiratory pandemic and indoor aeraulics of classrooms.

Authors:  P Carlotti; B Massoulié; A Morez; A Villaret; L Jing; T Vrignaud; A Pfister
Journal:  Build Environ       Date:  2022-01-19       Impact factor: 6.456

6.  Risk Analysis by Failure Modes, Effects and Criticality Analysis and Biosafety Management During Collective Air Medical Evacuation of Critically Ill Coronavirus Disease 2019 Patients.

Authors:  Lionel Koch; Olivier Nespoulous; Jean Turc; Cyril Linard; Patrick Martigne; Madeleine Beaussac; Sophie Murris; Olivier Ferraris; Marc Grandadam; Gaelle Frenois-Veyrat; Anne-Aurélie Lopes; Mathieu Boutonnet; Fabrice Biot
Journal:  Air Med J       Date:  2021-10-21

7.  All five COVID-19 outbreaks during epidemic period of 2020/2021 in China were instigated by asymptomatic or pre-symptomatic individuals.

Authors:  Caixin Yang; Sihui Zhang; Shan Lu; Jing Yang; Yanpeng Cheng; Yue Liu; Lijun Zhao; Jian Gong; Jianguo Xu
Journal:  J Biosaf Biosecur       Date:  2021-05-21

Review 8.  Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19).

Authors:  Ting Wu; Shuntong Kang; Wenyao Peng; Chenzhe Zuo; Yuhao Zhu; Liangyu Pan; Keyun Fu; Yaxian You; Xinyuan Yang; Xuan Luo; Liping Jiang; Meichun Deng
Journal:  Front Med (Lausanne)       Date:  2021-07-06

Review 9.  Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome.

Authors:  Sonia Villapol
Journal:  Transl Res       Date:  2020-08-20       Impact factor: 10.171

10.  Large SARS-CoV-2 Outbreak Caused by Asymptomatic Traveler, China.

Authors:  Andrei R Akhmetzhanov
Journal:  Emerg Infect Dis       Date:  2020-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.